11.47
20-9月-24 15:59:59
15 分の遅延
株式
+0.10
+0.88%
本日の幅
10.90 - 11.78
ISIN
N/A
ソース
NASDAQ
Alumis to Participate in Upcoming September Investor Conferences
03 9 2024 16:29:30 提供 Nasdaq GlobeNewswire
Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements
13 8 2024 16:05:27 提供 Nasdaq GlobeNewswire
Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis
29 7 2024 08:00:00 提供 Nasdaq GlobeNewswire